|
|
|
Insider
Information: |
Eshelman Fredric N |
Relationship: |
10% Owner |
City: |
Wilmington |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
8,151,654 |
|
Indirect Shares
|
3,933,809 |
|
|
Direct
Value |
$95,684,563 |
|
|
Indirect Value
|
$13,709,856 |
|
|
Total
Shares |
12,085,463 |
|
|
Total
Value |
$109,394,419 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
7
|
3
|
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
Percentage
Gain/Loss : |
-45.7%
|
-43.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-04-01 |
4 |
B |
$4.89 |
$220,122 |
I/I |
45,000 |
89,100 |
1.5 |
% |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-04-02 |
4 |
B |
$4.96 |
$35,792 |
I/I |
7,223 |
96,323 |
1.5 |
% |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-04-06 |
4 |
B |
$5.28 |
$233,715 |
I/I |
44,250 |
175,573 |
1.5 |
% |
|
PPDI |
Pharmaceutical Product De... |
CEO |
|
2005-05-26 |
4 |
OE |
$6.53 |
$5,706,592 |
D/D |
380,000 |
5,362,263 |
|
- |
|
LQDA |
Liquidia Technologies Inc |
10% Owner |
|
2020-07-02 |
4 |
B |
$8.00 |
$15,000,000 |
D/D |
1,875,000 |
7,034,744 |
2.45 |
% |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-12-20 |
4 |
OE |
$9.11 |
$600,130 |
I/I |
65,876 |
66,814 |
0 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-06-21 |
4 |
OE |
$9.11 |
$600,121 |
I/I |
65,875 |
132,689 |
0 |
- |
|
BHC |
Bausch Health Companies I... |
Director |
|
2017-05-03 |
4 |
D |
$9.66 |
$47,373 |
D/D |
(4,904) |
12,892 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2018-01-29 |
4 |
B |
$10.00 |
$3,350,000 |
D/D |
335,000 |
1,273,428 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-20 |
4 |
B |
$13.99 |
$6,505,350 |
D/D |
465,000 |
1,081,687 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-19 |
4 |
B |
$14.12 |
$177,898 |
D/D |
12,599 |
616,687 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-18 |
4 |
B |
$14.52 |
$182,937 |
D/D |
12,599 |
604,088 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-24 |
4 |
B |
$14.79 |
$214,692 |
D/D |
14,516 |
1,096,203 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-04 |
4 |
B |
$14.92 |
$106,052 |
D/D |
6,922 |
1,353,125 |
3.92 |
- |
|
GTHX |
G1 Therapeutics Inc |
Director |
|
2017-05-22 |
4 |
B |
$15.00 |
$4,500,000 |
I/I |
300,000 |
3,439,151 |
2.25 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-25 |
4 |
B |
$15.35 |
$3,837,500 |
D/D |
250,000 |
1,346,203 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-21 |
4 |
B |
$15.48 |
$193,005 |
D/D |
12,468 |
1,660,202 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-07 |
4 |
B |
$15.69 |
$112,152 |
D/D |
7,148 |
1,360,273 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-18 |
4 |
B |
$15.87 |
$374,929 |
D/D |
23,625 |
1,647,734 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-08 |
4 |
B |
$16.00 |
$4,000,000 |
D/D |
250,000 |
1,610,273 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-25 |
4 |
B |
$16.00 |
$108,832 |
D/D |
6,802 |
1,682,282 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2012-05-21 |
4 |
B |
$16.15 |
$38,760 |
D/D |
2,400 |
2,215,435 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-23 |
4 |
B |
$16.22 |
$247,809 |
D/D |
15,278 |
1,675,480 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-09 |
4 |
B |
$16.26 |
$15,398 |
D/D |
947 |
1,611,220 |
3.92 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-11-10 |
4 |
B |
$16.48 |
$212,411 |
D/D |
12,889 |
1,624,109 |
3.92 |
- |
|
148 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|